A biologic risk model for stage I lung cancer: Immunohistochemical analysis of 408 patients with the use of ten molecular markers
- 30 April 1999
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 117 (4) , 736-743
- https://doi.org/10.1016/s0022-5223(99)70294-1
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Cancer statistics, 1998CA: A Cancer Journal for Clinicians, 1998
- Revisions in the International System for Staging Lung CancerChest, 1997
- Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrenceCancer, 1995
- Survival in early-stage non-small cell lung cancerThe Annals of Thoracic Surgery, 1995
- Is T factor of the TNM staging system a predominant prognostic factor in pathologic stage I non-small-cell lung cancer?The Journal of Thoracic and Cardiovascular Surgery, 1993
- Cancer recurrence after resection: T1 N0 non-small cell lung cancerThe Annals of Thoracic Surgery, 1990
- Histopathologic prognostic factors in adenocarcinomas of the peripheral lung less than 2 CM in diameterCancer, 1988
- Lung cancer classification: The relationship of disease extent and cell type to survival in a clinical trials populationJournal of Surgical Oncology, 1987
- A New International Staging System for Lung CancerChest, 1986
- Postsurgical Stage I Bronchogenic Carcinoma: Morbid Implications of Recurrent DiseaseThe Annals of Thoracic Surgery, 1984